Announcements Trials
Browse Landscape

Phase

Phase 2 46Phase 3 12Phase 1 12Phase 1/2 6Phase NA 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Colonic Neoplasms 2Rectal Neoplasms 1Colorectal Neoplasms 1

Interventions

X-Rays 2sodium thiosulfate 1Watchful Waiting 1Specimen Handling 1Reverse Transcriptase Polymerase Chain Reaction 1Receptor Protein-Tyrosine Kinases 1Radiotherapy 1Proctectomy 1Platinum 1Observation 1Microscopy, Electron 1Magnetic Resonance Spectroscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Granulocyte-Macrophage Colony-Stimulating Factor 1Folfox protocol 1Ferrosoferric Oxide 1Enzyme-Linked Immunosorbent Assay 1Drug Therapy 1Doxorubicin 1Dasatinib 1Cytoreduction Surgical Procedures 1Copper 1Cisplatin 1Cholecalciferol 1Cetuximab 1Capecitabine 1CYT-6091 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Rectal Neoplasms × Cetuximab × Clear all
NCT00835679 2014-05-23

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Terminated
9 enrolled 3 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡